The hepatitis B virus (HBV), discovered in 1966, infects more than 350 million people
worldwide. 1 Hepatitis B is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular …

Infection with hepatitis B virus (HBV) results in a broad spectrum of liver disease, ranging
from subclinical infection to acute, self-limited hepatitis and fatal, fulminant hepatitis …

Infection with hepatitis B virus (HBV) may lead to acute or chronic hepatitis. HBV infections
were previously much more frequent but there are still 240 million chronic HBV carriers …

The hepatitis B virus (HBV) is an enveloped, hepatotrophic, oncogenic hepadnavirus that is
noncytopathic for hepatocytes. HBV infection results in a variety of outcomes that are …

Hepatitis B virus (HBV) is a virus that infects about 350,000,000 people worldwide with a
clinical spectrum of acute hepatitis, the healthy carrier state, cirrhosis and hepatocellular …

This infographic about hepatitis B virus explores its replication cycle, natural history of
infection and pathogenesis, and how this can be controlled and treated. Hepatitis B virus …

Although hepatitis B is an ancient disease, most of the advances in our knowledge of its
epidemiology, prevention, pathogenesis, natural history and treatment were made in the last …

Approximately 5% of the world population is infected by the hepatitis B virus (HBV) that
causes a necroinflammatory liver disease of variable duration and severity. Chronically …

Hepadnaviruses (hepatitis B viruses) cause transient and chronic infections of the liver.
Transient infections run a course of several months, and chronic infections are often lifelong …

Hepatitis B virus (HBV) infects more than 300 million people worldwide and is a common
cause of liver disease and liver cancer. HBV, a member of the Hepadnaviridae family, is a …